Pharmaceutical composition comprising a GLP-1-agonist and methionine

US12303598B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Anette Brunner-Schwarz · Frankfurt, DE
• Werner Mueller · Cologne, DE
• Verena Siefke-Henzler · Frankfurt, DE

Key dates

• Filing date: May 18, 2022
• Grant date: May 20, 2025
• Expiry date: Mar 4, 2043

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P3/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.